TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UroMedical Halland AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
24,835
|
23,120
|
18,454 |
| Financial expenses |
12,287
|
0
|
0 |
| Earnings before taxes |
-7,641
|
6,843
|
4,659 |
| EBITDA |
4,840
|
6,713
|
4,704 |
| Total assets |
8,415
|
14,585
|
18,702 |
| Current assets |
6,885
|
13,971
|
17,827 |
| Current liabilities |
3,855
|
1,632
|
6,607 |
| Equity capital |
3,959
|
12,362
|
11,543 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
12
|
12
|
12 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.0%
|
84.8%
|
61.7% |
| Turnover per employee |
2,070
|
1,927
|
1,538 |
| Profit as a percentage of turnover |
-30.8%
|
29.6%
|
25.2% |
| Return on assets (ROA) |
55.2%
|
46.9%
|
24.9% |
| Current ratio |
178.6%
|
856.1%
|
269.8% |
| Return on equity (ROE) |
-193.0%
|
55.4%
|
40.4% |
| Change turnover |
1,297
|
3,357
|
1,488 |
| Change turnover % |
6%
|
17%
|
9% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.